Société Vinings Holdings Inc. Other OTC
Actions
NDYN
US92744A1051
Produits pharmaceutiques
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Mehalick
CEO | Chief Executive Officer | 56 | 28/10/22 |
Brian Cogley
DFI | Director of Finance/CFO | 38 | 17/05/23 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 28/10/22 |
Colleen Delaney
CTO | Chief Tech/Sci/R&D Officer | 57 | 30/08/23 |
Christine Sheehy
CMP | Compliance Officer | 57 | 28/10/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 62 | 28/10/22 | |
Director/Board Member | 55 | 28/10/22 | |
Christine Sheehy
CMP | Compliance Officer | 57 | 28/10/22 |
Gene Salkind
BRD | Director/Board Member | 70 | 28/10/22 |
Chris Calise
BRD | Director/Board Member | 51 | 28/10/22 |
David Mehalick
CEO | Chief Executive Officer | 56 | 28/10/22 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 28/10/22 |
Director/Board Member | 56 | 28/10/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 37 118 593 | 25 373 891 ( 68,36 %) | 0 | 68,36 % |
Coordonnées société
Coeptis Therapeutics Holdings, Inc.
105 Bradford Road Suite 420
15090, Wexford
+
http://www.coeptistx.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+43,42% | 749 Md | |
+39,42% | 605 Md | |
-6,44% | 351 Md | |
+19,57% | 328 Md | |
+8,72% | 292 Md | |
+11,92% | 216 Md | |
-2,62% | 214 Md | |
+0,47% | 167 Md | |
+6,51% | 165 Md |